top
Search terms
Results 1 - 2 of 2 - ordered by :
Ehjournal

Furthermore, the EMPA-REG OUTCOME trial using the novel antihyperglycaemic agent, empagliflozin,8 a selective sodiumglucose co- transporter inhibitor, significantly reduced cardiovascular mortality; ...

European Heart Journal, Lüscher, Thomas F.

Date : 07/02/2016 Item size : 183395 bytes
Ehjournal

Furthermore, the EMPA-REG OUTCOME trial using the novel antihyperglycaemic agent, empagliflozin,8 a selective sodiumglucose co- transporter inhibitor, significantly reduced cardiovascular mortality; ...

European Heart Journal, Lüscher, Thomas F.

Date : 07/02/2016 Item size : 208663 bytes